Control of Fibrinolysis by the Lung Epithelium
Control of Fibrinolysis by the Lung Epithelium
批准号:
7312552
负责人:
Sreerama Shetty
金额:
$33.71万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
RNA binding proteinacute disease /disorderanimal tissueenzyme activityfibrinolysisheterogeneous nuclear ribonucleoproteinhuman tissueimmunocytochemistrylunglung disordermessenger RNAmolecular cloningpathologic processphosphoglycerate kinasephosphorylationplasminogen activatorpleural cavitypolymerase chain reactionposttranscriptional RNA processingprotein protein interactionprotein structure functionreceptor expressionrespiratory epitheliumtranscription factorurokinasewestern blottings
中文摘要
尿激酶(UPA)-uPA受体(UPAR)系统通过蛋白水解性重塑、非蛋白水解性信号转导以及细胞迁移和有丝分裂的调节参与了肺部炎症和肿瘤的发病过程。在急性肺损伤(ALL)患者中,uPA介导的纤溶活性抑制促进了肺泡纤维蛋白沉积,有利于加速纤维化修复。我们最近证实,肺上皮细胞在转录后水平上调节uPA和uPAR的mRNA稳定性。我们假设肺上皮细胞uPA和uPAR的表达是通过这些新发现的转录后途径来调节的,从而影响与ALL及其修复密切相关的上皮细胞反应。我们的目标是阐明这些途径。这些途径目前还不清楚,代表着我们对发病机制的理解的一个重要缺口,我们的所有初步数据支持这一假说,并表明磷酸甘油酸激酶(PGK)和其他新发现的uPAR和uPA mRNA结合蛋白-mRNA相互作用控制着肺上皮细胞uPAR和uPA的表达。我们的具体目标是:1)确定PGK和另一个新的
可识别的uPAR基因编码区结合蛋白调节肺上皮细胞uPAR的表达
细胞。2)阐明新发现的3‘-非翻译区(3’-UTR)与uPAR mRNA结合蛋白相互作用对uPAR表达的影响。3)探讨PGK和HNRNPC调节细胞因子介导的肺上皮细胞uPAR表达的机制(S)。4)克隆uPA mRNABp基因,并研究其对肺上皮细胞uPA表达的调控作用。这些研究将扩大我们对肺上皮细胞调节uPAR和uPA表达的机制的了解,并加速开发治疗ALI及其修复的新疗法。
英文摘要
The urokinase (uPA)-uPA receptor (uPAR) system is implicated in the pathogenesis of pulmonary inflammation and neoplasia via proteolytic remodeling, nonproteolytic signaling and regulation of cell migration and mitogenesis. In patients with acute lung injury (All), depressed uPA-mediated fibrinolytic activity promotes alveolar fibrin deposition, favoring accelerated fibrotic repair. We recently demonstrated that lung epithelial cells regulate both uPA and uPAR at the posttranscriptional level of mRNA stability. We hypothesize that expression of uPA and uPAR by lung epithelial cells is regulated via these newly appreciated posttranscriptional pathways to influence epithelial cell responses germane to All and its repair. Our objective is to elucidate these pathways. These pathways are poorly understood at this time, representing an important gap in our understanding of the pathogenesis of ALL Our preliminary data support the hypothesis and show that phosphoglycerate kinase (PGK) and other newly appreciated uPAR and uPA mRNA binding protein-mRNA interactions control uPAR and uPA expression by lung epithelial cells. Our Specific Aims are: 1) To determine how PGK and another newly
recognized uPAR mRNA coding region binding protein regulate uPAR expression in lung epithelial
cells. 2) To elucidate the role of newly recognized 3'-untranslated region (3'UTR) uPAR mRNA-binding protein interactions on uPAR expression. 3) To determine mechanism(s) by which PGK and hnRNPC, another putative regulatory protein, regulate cytokine mediated expression of uPAR in lung epithelial cells. 4) To clone the cDNA for the uPA mRNABp and determine how it regulates uPA expression in lung epithelial cells. These studies will extend our - understanding of mechanisms by which lung epithelial cells regulate uPAR and uPA expression and hasten the development of novel therapeutics for ALI and its repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Silica-induced Lung Injury by Plasminogen Activator Inhibitor-1
-
批准号:10370063
-
项目类别:
-
资助金额:$40.43万
-
财政年份:2022
-
负责人:Sreerama Shetty
-
依托单位:
Development, Formulation and Inhalational Delivery of a New Peptide for ILD
-
批准号:10318218
-
项目类别:
-
资助金额:$44.86万
-
财政年份:2020
-
负责人:Sreerama Shetty
-
依托单位:
Development, Formulation and Inhalational Delivery of a New Peptide for ILD
-
批准号:10524032
-
项目类别:
-
资助金额:$44.84万
-
财政年份:2020
-
负责人:Sreerama Shetty
-
依托单位:
Control of fibrosing lung disease by p53-miR-34a-targeted therapeutics
-
批准号:9276124
-
项目类别:
-
资助金额:$39.18万
-
财政年份:2016
-
负责人:Sreerama Shetty
-
依托单位:
Role of p53 and PAI-1 in tobacco smoke exposure induced lung injury
-
批准号:9321809
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2016
-
负责人:Sreerama Shetty
-
依托单位:
Control of fibrosing lung disease by p53-miR-34a-targeted therapeutics
-
批准号:9157281
-
项目类别:
-
资助金额:$39.18万
-
财政年份:2016
-
负责人:Sreerama Shetty
-
依托单位:
Regulation of lung epithelial injury by plasminogen activator inhibitor-1
-
批准号:7990804
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2010
-
负责人:Sreerama Shetty
-
依托单位:
Regulation of lung epithelial injury by plasminogen activator inhibitor-1
-
批准号:8091232
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2010
-
负责人:Sreerama Shetty
-
依托单位:
Control of Fibrinolysis by the Lung Epithelium
-
批准号:7029468
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2005
-
负责人:Sreerama Shetty
-
依托单位:
Regulation of Lung Epithelial Fibrinolysis by Urokinase
-
批准号:6531624
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2002
-
负责人:Sreerama Shetty
-
依托单位:
Regulation of Lung Epithelial Fibrinolysis by Urokinase
-
批准号:6947206
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2002
-
负责人:Sreerama Shetty
-
依托单位:
Regulation of Lung Epithelial Fibrinolysis by Urokinase
-
批准号:6603766
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2002
-
负责人:Sreerama Shetty
-
依托单位:
Regulation of Lung Epithelial Fibrinolysis by Urokinase
-
批准号:6795022
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2002
-
负责人:Sreerama Shetty
-
依托单位:
CONTROL OF FIBRINOLYTIC PATHWAYS IN LUNG DISEASE
-
批准号:6390318
-
项目类别:
-
资助金额:$15.86万
-
财政年份:1999
-
负责人:Sreerama Shetty
-
依托单位:
Control of Fibrinolytic Pathways in Lung Disease
-
批准号:6827618
-
项目类别:
-
资助金额:$27.5万
-
财政年份:1999
-
负责人:Sreerama Shetty
-
依托单位:
CONTROL OF FIBRINOLYTIC PATHWAYS IN LUNG DISEASE
-
批准号:2835089
-
项目类别:
-
资助金额:$15.12万
-
财政年份:1999
-
负责人:Sreerama Shetty
-
依托单位:
CONTROL OF FIBRINOLYTIC PATHWAYS IN LUNG DISEASE
-
批准号:6527558
-
项目类别:
-
资助金额:$16.24万
-
财政年份:1999
-
负责人:Sreerama Shetty
-
依托单位:
CONTROL OF FIBRINOLYTIC PATHWAYS IN LUNG DISEASE
-
批准号:6184790
-
项目类别:
-
资助金额:$15.5万
-
财政年份:1999
-
负责人:Sreerama Shetty
-
依托单位:
Control of Fibrinolysis by the Lung Epithelium
-
批准号:7492131
-
项目类别:
-
资助金额:$37.48万
-
财政年份:--
-
负责人:Sreerama Shetty
-
依托单位:
Control of Fibrinolysis by the Lung Epithelium
-
批准号:7898737
-
项目类别:
-
资助金额:$35.12万
-
财政年份:--
-
负责人:Sreerama Shetty
-
依托单位: